BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 27504812)

  • 1. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
    Singh H; Balouch F; Noble C; Lewindon P
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
    Mínguez Sabater A; Conde Amiel I; Ladrón Abia P; Martínez Delgado S; Camarasa Pérez Á; Berenguer M
    Gastroenterol Hepatol; 2022 Mar; 45(3):177-185. PubMed ID: 34052401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations.
    Valentino PL; Feldman BM; Walters TD; Griffiths AM; Ling SC; Pullenayegum EM; Kamath BM
    Inflamm Bowel Dis; 2015 Dec; 21(12):2848-56. PubMed ID: 26273817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigative MRI cholangiopancreatography for primary sclerosing cholangitis-type lesions in children with IBD.
    Alexopoulou E; Xenophontos PE; Economopoulos N; Spyridopoulos TN; Papakonstantinou O; Panayotou I; Dimakou K; Roma E; Kelekis NL
    J Pediatr Gastroenterol Nutr; 2012 Sep; 55(3):308-13. PubMed ID: 22569526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.
    Deneau M; Jensen MK; Holmen J; Williams MS; Book LS; Guthery SL
    Hepatology; 2013 Oct; 58(4):1392-400. PubMed ID: 23686586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium.
    Laborda TJ; Ricciuto A; Aumar M; Carman N; DiGuglielmo M; Draijer LG; Furuya KN; Gupta N; Koot BGP; Loomes KM; Lytvyak E; Martinez M; Miloh T; Montano-Loza AJ; Perito ER; Sathya P; Shah U; Shteyer E; Singh R; Taylor A; Valentino PL; Vitola B; Zerofsky M; Zizzo A; Deneau MR
    J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):459-464. PubMed ID: 32740528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
    Tibdewal P; Bhatt P; Jain A; Gupta D; Bhatia S; Shukla A
    Indian J Gastroenterol; 2019 Aug; 38(4):295-302. PubMed ID: 31515764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
    Lee WS; Karthik SV; Ng RT; Ong SY; Ong C; Chiou FK; Wong SY; Quak SH; Aw MM
    Pediatr Neonatol; 2019 Aug; 60(4):396-404. PubMed ID: 31409456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.